Stockreport

QIAGEN Receives U.S. FDA EUA for QIAstat-Dx test kit, First and Only Syndromic Solution Integrating Detection of SARS-CoV-2 Coronavirus

Qiagen N.V. Common Shares  (QGEN) 
Last qiagen n.v. common shares earnings: 2/4 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: corporate.qiagen.com/investor-relations
PDF First syndromic testing solution to be deployed in epidemic can differentiate novel coronavirus from 21 other serious respiratory infectionsQIAstat-Dx Respiratory SARS-C [Read more]